Skip to main content
Georgia Public Broadcasting Logo
  • Watch

    Featured Specials and Programs

    • All Creatures Great and Small
    • Antiques Roadshow
    • PBS News Hour
    • Miss Scarlet & The Duke
    • Finding Your Roots
    • Doc Martin
    All Programs

    GPB Originals

    • Georgia Legends
    • Lawmakers
    • A Fork in the Road
    • View Finders
    • Georgia Outdoors
    • Your Fantastic Mind
    GPB Originals

    Browse by Genre

    • Arts & Music
    • Culture
    • Drama
    • Food
    • History
    • News & Public Affairs
    • TV Schedule
    • GPB Programs
    • PBS Passport
    • TV Highlights this Week
    • PBS KIDS
    • Ways to Watch
    • Newsletters
    • Contact GPB
  • Listen

    Featured Programs

    • The Daily
    • Morning Edition
    • All Things Considered
    • Serendipity
    • John Lemley's City Cafe
    • Fresh Air
    • Here and Now
    • Code Switch/Life Kit
    • Wait Wait... Don't Tell Me!
    All Programs

    Podcasts

    • GA Today
    • Salvation South
    • Battleground: Ballot Box
    • Football Fridays in Georgia
    • Narrative Edge
    • Peach Jam Podcast
    • A Fork in the Road
    • Radio Schedule
    • GPB Classical
    • Radio Programs
    • Podcasts
    • GPB News
    • Find Your Station
    • Ways to Listen
    • Contact GPB
    • Newsletters
  • Learn

    Featured

    • Chemistry Matters
    • Classroom Conversations Podcast
    • GASHA Go! World
    • Georgia Farmcraft®
    • Georgia Classroom
    • Georgia Studies Collection
    • Econ Express
    • Let’s Go Enviro
    • Let's Learn GA!
    • Lights, Camera, Budget!
    • Live Explorations
    • Physics in Motion
    • Student Voices Collective
    • Virtual Field Trips
    • VR in the Classroom
    • Writers Contest

    For Kids & Teachers

    • GPB Games
    • PBS KIDS
    • PBS LearningMedia

    • on Twitter
    • on Facebook
    • on Instagram
    • on YouTube
    • on Email
  • News

    Featured Programs & Series

    • Lawmakers
    • Lawmakers: Beyond the Dome
    • 1A
    • Battleground: Ballot Box
    • GA Today Podcast
    • Storycorps
    • Narrative Edge

    More GPB News

    • Politics
    • Georgia News
    • Justice
    • Arts & Life
    • Health
    All GPB News
    • Radio Schedule
    • Radio Stations
    • GPB Apps
    • Podcasts
    • Contact GPB News
    • Follow Us on Apple News
    • Newsletters
  • Sports

    GHSA Sports

    • Football
    • Basketball
    • Cheerleading
    • On Demand
    • GPB Sports Blog
    All Sports

    High School Football

    • Scores & Schedule
    • On Demand
    • Teams
    • Rankings
    • Brackets
    • Heads Up Georgia
    Football Home
    • GPB Sports App
    • GPB Sports Blog
    • GPB Sports OnDemand
  • Events

    Browse by Type

    • Community
    • Donor
    • Kids & Family
    • Screenings
    All Events

    Browse by Category

    • Education
    • News
    • Sports
    • Television

    Sign up to receive GPB Event announcements via Email.

    Sign up

    • on Twitter
    • on Facebook
    • on Instagram
  • Kids & Families

    For Kids

    • Video
    • Games

    For Parents & Caregivers

    • Kids & Families Blog
    • Kids & Families Events
    • GPB KIDS - Ways to Watch
  • Support Us

    Support GPB

    • Ways to Give
    • Planned Giving
    • Sustainers
    • GPB Passport
    • Leadership Giving
    • Corporate Sponsorship
    • Vehicle Donations
    • GPB Next
    • Matching Gifts
  • Search
GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate

Media Utility

  • TV Schedule
  • Podcasts
  • Apps

Don't Miss

Don't Miss:

  • TV Highlights This Week
  • Watch: GPB's Lawmakers
  • Explore GPB Passport
Listen Live Listen Live Watch Live Watch Live
GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate

News Articles: Alzheimer's research

Leading neuroscientists say that ongoing disruptions in federal funding are causing many young scientists in the field to reconsider their career choice — with potentially dire consequences for research into Alzheimer's, autism and other brain disorders.

Tagged as: 

  • Science

As funding falters, young brain scientists rethink careers in research

Research on brain disorders may slow as young neuroscientists struggle to find jobs and research grants.

November 15, 2025
|
By:
  • Jon Hamilton
Three scientists learned they carry genes that significantly increase their risk for Alzheimer's. Here's how they're grapping with the news, and working to keep their brains healthy.

Tagged as: 

  • Science

These scientists found Alzheimer's in their genes. Here's what they did next

Three scientists learned they carry genes that dramatically increase their risk for Alzheimer's disease. Now they're working to keep their brains healthy.

September 02, 2025
|
By:
  • Jon Hamilton
A big new study finds that diet, exercise and other lifestyle changes can significantly enhance the health of aging brains.

Tagged as: 

  • Science

Trying to keep your brain young? A big new study finds these lifestyle changes help

A study of more than 2,100 people ages 60 to 79 found that an intensive two-year program of mental and physical activities, along with a heart-healthy diet, improved memory and thinking.

July 29, 2025
|
By:
  • Jon Hamilton
Joe Walsh, who has Alzheimer's disease, is accompanied by his wife, Karen Walsh, to an appointment at Brigham and Women's Hospital in Boston. Joe is receiving an experimental therapy to treat Alzheimer's.

Tagged as: 

  • Science

Can this nasal spray slow down Alzheimer's? One couple is helping scientists find out

Joe Walsh is the first Alzheimer's patient to be treated with an experimental nasal spray designed to reduce inflammation in the brain.

May 31, 2025
|
By:
  • Jon Hamilton
New tests of blood and spinal fluid could help doctors quickly identify patients who would most benefit from treatment.

Tagged as: 

  • Science

Latest Alzheimer's lab tests focus on memory loss, not brain plaques

New tests of blood and spinal fluid can identify people experiencing memory loss from Alzheimer's disease.

April 03, 2025
|
By:
  • Jon Hamilton
Ione and Doug Whitney, February, 2025.

Tagged as: 

  • Science

His genes forecast Alzheimer's. His brain had other plans.

Doug Whitney was supposed to develop Alzheimer's by 50. Now scientists are trying to understand why his brain remains healthy at 75.

February 12, 2025
|
By:
  • Jon Hamilton
Glowing lines and spots encircling a human brain

Tagged as: 

  • Research News

This metabolic brain boost revives memory in Alzheimer’s mice

An experimental cancer drug that helps the brain turn glucose into energy was able to reverse memory loss in a mouse model of Alzheimer’s disease.

September 02, 2024
|
By:
  • Jon Hamilton
New blood tests that help detect Alzheimer's disease are opening up a new era in diagnosis and treatment, doctors say.

Tagged as: 

  • Research News

New blood tests can help diagnose Alzheimer's. Are doctors ready for what's next?

A new generation of blood tests can help diagnose Alzheimer’s disease. But many doctors don’t yet know how to use them.

August 02, 2024
|
By:
  • Jon Hamilton
A key protein called Reelin may help stave off Alzheimer's disease, according to a growing body of research.

Tagged as: 

  • Research News

A protein called Reelin keeps popping up in brains that resist aging and Alzheimer’s

Early in life, the protein Reelin helps assemble the brain. Later on, it appears to protect the organ from Alzheimer’s and other threats to memory and thinking.

July 29, 2024
|
By:
  • Jon Hamilton
A precisely timed pulse to a brain area just behind the ear can help reduce memory deficits in patients suffering moderate to severe traumatic brain injuries.

Tagged as: 

  • Research News

When a brain injury impairs memory, a pulse of electricity may help

A severe traumatic brain injury can make it hard to remember recent events or conversations. But a form of brain stimulation appears to ease this memory deficit.

August 11, 2023
|
By:
  • Jon Hamilton
The Food and Drug Administration has fully approved Leqembi, the first drug shown to slow down Alzheimer's disease.

Tagged as: 

  • Health Care

Alzheimer's drug Leqembi gets full FDA approval. Medicare coverage will likely follow

The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.

July 07, 2023
|
By:
  • Jon Hamilton
In patients with Alzheimer's disease, a substance called beta-amyloid can form toxic clumps in between neurons. Drugs like lecanemab are designed to remove amyloid-beta from the brain.

Tagged as: 

  • Science

An Alzheimer's drug is on the way, but getting it may still be tough. Here's why

The Food and Drug Administration is expected to grant full approval to the Alzheimer's drug lecanemab by July 6. But access to the drug may still be limited.

June 26, 2023
|
By:
  • Jon Hamilton
A new study finds that stimulating the brain during sleep can improve memory.

Tagged as: 

  • Research News

Scientists zap sleeping humans' brains with electricity to improve their memory

Scientists have shown that deep brain stimulation during sleep can help people retain new information. The approach could help people with memory problems related to disorders like Alzheimer's.

June 02, 2023
|
By:
  • Jon Hamilton
U.S. health officials approved Leqembi, a new Alzheimer's drug that modestly slows the brain disease. The FDA granted accelerated approval Friday for patients in early stages of Alzheimer's.

Tagged as: 

  • Science

FDA approves Alzheimer's drug that appears to modestly slow disease

An Alzheimer's drug that removes the substance amyloid from the brain has received a conditional approval from the FDA. A large study found the drug decreased the loss of thinking and memory by 27%.

January 07, 2023
|
By:
  • Jon Hamilton
This illustration made available by the National Institute on Aging/National Institutes of Health depicts cells in an Alzheimer's-affected brain. An experimental drug modestly slowed the brain disease's progression, researchers reported Tuesday.

Tagged as: 

  • Science

Study: Alzheimer's drug shows modest success slowing declines in memory, thinking

In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.

November 30, 2022
|
By:
  • Jon Hamilton
  • Load More

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News

Footer

Footer First Nav (Main Menu)

  • Watch
  • Listen
  • Learn
  • News
  • Sports
  • Events
  • Kids & Families
  • Support Us
  • Search

Footer Second Nav Menu

  • Help Center
  • About GPB
  • Contact Us
  • Closed Captioning
  • Directions
  • Studio Production
  • Program Submissions

Footer Third Nav Menu

  • Support Us
  • Careers
  • Accessibility
  • FCC Public Files
  • Drawing Rules
  • News Media Request
  • Open Records and Document Retention Policy
  • Privacy Policy

Georgia Public Broadcasting

260 14th St. NW
Atlanta, GA 30318
United States

(404) 685-2400 In Atlanta
(800) 222-4788 Outside Atlanta
ask@gpb.org

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News
© Copyright 2026, Georgia Public Broadcasting. All Rights Reserved. Georgia Public Radio® GPTV®